Latest / Money Making Conversations Master Class / Entrepreneur: He's making it easier for people with Opioid Use Disorder to commit to their methadone treatment program.
Transcript
- 0:05Speaker 1: Welcome to the show. I am Rashawn McDonald, the host
- 0:08Speaker 1: of Money Making Conversations Masterclass, where we encourage people to
- 0:11Speaker 1: stop reading other people's success stories and start planning their own.
- 0:16Speaker 1: Listen up as I interview entrepreneurs.
- 0:18Speaker 2: From around the country, talk to celebrities and ask them
- 0:22Speaker 2: how they are running their companies and speak with nonprofits
- 0:25Speaker 2: who are making a difference in their local communities. Now
- 0:28Speaker 2: sit back and listen as we unlock the secrets to
- 0:30Speaker 2: their success on Money Making Conversations Masterclass.
- 0:35Speaker 1: Welcome, welcome. It's another day. It's another time for Money
- 0:39Speaker 1: Making Conversations Masterclass. I am the host of the show,
- 0:42Speaker 1: Rashawn McDonald. I created it in 2017 as an idea
- 0:46Speaker 1: to be able to marry information that successful entrepreneurs in
- 0:50Speaker 1: the working platforms can share their success stories or their
- 0:54Speaker 1: stories of optimism, their stories of the moments when they
- 0:58Speaker 1: think it was all going to go bad and how
- 0:59Speaker 1: they turned it right at the ship. And that's what
- 1:02Speaker 1: Money Making Conversations Masterclass is. I do have celebrities who
- 1:04Speaker 1: come on the show who have an entrepreneurial eye and
- 1:07Speaker 1: they can share their stories because we're all in the
- 1:09Speaker 1: same boat. That's to be successful, to employ people, pay
- 1:13Speaker 1: our taxes on time, and also create generational wealth. That
- 1:17Speaker 1: is what Money Making Conversations Masterclass is all about. The
- 1:20Speaker 1: interviews and information that this show provides really is for everyone.
- 1:24Speaker 1: It's time to stop reading other people's success stories and
- 1:27Speaker 1: start living your own. Now, if you want to be
- 1:29Speaker 1: a guest on my show, please visit MoneyMakingConversations.com. That's MoneyMakingConversations.com
- 1:37Speaker 1: and click the Be A Guest button. You submit the information,
- 1:40Speaker 1: who you are, everything in the background, and then I
- 1:43Speaker 1: contact you if you submit all the right information to
- 1:46Speaker 1: be a guest on my show. Now, let's get this
- 1:48Speaker 1: show rolling. It's a different show because we're talking about
- 1:52Speaker 1: The world of people who are impacted by what's going
- 1:55Speaker 1: on and sometimes can't control their own narrative. There are organizations,
- 1:58Speaker 1: there are businesses out there that are helping people right
- 2:01Speaker 1: to ship. My guest on the show today makes it
- 2:04Speaker 1: easier for people with opioid use disorder, that's OUD, to
- 2:09Speaker 1: commit to their methadone treatment program. He has witnessed the
- 2:12Speaker 1: devastating impact of opioid use disorder on individuals, families, and
- 2:17Speaker 1: their communities. Please welcome to Money Making Conversations Masterclass, Dr.
- 2:21Speaker 1: Michael Giles. How you doing, sir?
- 2:24Speaker 3: I'm doing well. Thanks for having me, Rashawn. I know.
- 2:26Speaker 1: Prior to the interview, I called Michael because of the
- 2:30Speaker 1: serious nature. And I don't want people to turn off
- 2:32Speaker 1: because it's serious or it's dark. No, this is life.
- 2:34Speaker 1: This is about people who are trying to get on
- 2:38Speaker 1: with their lives that have been impacted by a drug
- 2:40Speaker 1: that's been devastating this country for a number of years now.
- 2:44Speaker 1: You've seen a lot of news stories out there where
- 2:47Speaker 1: larger companies have been sued and judgments have been won
- 2:50Speaker 1: against them and communities, not just individuals, but communities and
- 2:54Speaker 1: have been destroyed by this drug, opioid drug. Well, people
- 2:59Speaker 1: want to get on with their life. And sometimes this
- 3:01Speaker 1: drug won't allow all the treatment technique that's being offered
- 3:05Speaker 1: to them won't allow them to get on with their lives.
- 3:08Speaker 1: So I invited Michael on the show to talk about it.
- 3:11Speaker 1: Give us a little background about you before we get
- 3:13Speaker 1: started there, Michael.
- 3:15Speaker 3: Sure. So I'm a psychiatrist and I started a company
- 3:19Speaker 3: called Sonara Health. Mm hmm. during the last year of
- 3:22Speaker 3: my psychiatry training, based on my experience working in an
- 3:27Speaker 3: opioid treatment program, which is the only facility in the
- 3:30Speaker 3: United States where you can receive methadone. So there's about
- 3:33Speaker 3: 2,000 of these OTPs across the United States, and the
- 3:38Speaker 3: standard of care is for patients to drive to this
- 3:40Speaker 3: clinic every day for an initial period of time, wait
- 3:45Speaker 3: in line, and then take a dose of the medication
- 3:47Speaker 3: methadone in front of a care provider. Right. And this
- 3:52Speaker 3: requirement for daily visits is really strenuous for patients who
- 3:56Speaker 3: have jobs or are in education or have kids to
- 4:01Speaker 3: take care of. And, you know, I would, you know,
- 4:05Speaker 3: when I was on this rotation, I would advocate to
- 4:06Speaker 3: these patients to get take-home methadone so they wouldn't have
- 4:09Speaker 3: to come in every day. And the provider often didn't
- 4:11Speaker 3: trust the patient. It seemed like if someone built a
- 4:15Speaker 3: tool that gave patients the opportunity to demonstrate how they're
- 4:19Speaker 3: using the medication at home that these patients could then
- 4:22Speaker 3: get take-home methadone instead of having to come into the
- 4:25Speaker 3: clinic every day. And so that's exactly what our application
- 4:29Speaker 3: was designed to do. We launched at the end.
- 4:33Speaker 1: Before we get too far into the whole process, because
- 4:36Speaker 1: there are steps to that. Like you always say, the
- 4:38Speaker 1: doctor didn't trust the patient. Now, we've got to talk
- 4:40Speaker 1: about the idea of you creating this concept and then
- 4:44Speaker 1: implementing the concept, I guess, a beta period, and then
- 4:49Speaker 1: being able to implement it for doctors to trust you.
- 4:51Speaker 1: So when did you first implement the concept as being
- 4:54Speaker 1: a possibility? Because like you said, you've seen this drug
- 4:57Speaker 1: devastate the community. You've seen this drug and the way
- 5:01Speaker 1: it was being, the methadone was being applied. They had
- 5:03Speaker 1: to come up here every day, like you said, disrupt
- 5:05Speaker 1: their life. When did this idea pop in your head?
- 5:09Speaker 3: It happened during my residency. I was training. I was
- 5:14Speaker 3: just talking to the attending physicians, like the boss doctor,
- 5:17Speaker 3: and I was asking them, like, you know, what would
- 5:19Speaker 3: it take for these patients to, like, get some take-home methadone? And,
- 5:24Speaker 3: you know, the attending physician, the response would be, if
- 5:28Speaker 3: I understood how they were using the medication, I'd be
- 5:30Speaker 3: more comfortable giving them, you know, multiple doses so they
- 5:33Speaker 3: don't have to come in every day. Mm-hmm. kind of
- 5:36Speaker 3: the business concept was designed to solve a specific problem. Right.
- 5:41Speaker 3: And it's a problem of patient provider trust. That's really
- 5:44Speaker 3: what our product does.
- 5:46Speaker 1: So when you talk about this, you know, because it's
- 5:48Speaker 1: all about trust, because like I said, the doctors see
- 5:51Speaker 1: there is a remedy, but they have no solution. And
- 5:56Speaker 1: so when you started sitting down, did you sit down
- 5:59Speaker 1: with family members, sit down with some friends, sit down
- 6:01Speaker 1: with investors to start building this concept out? And because
- 6:06Speaker 1: everything is a great concept, but it also has to be,
- 6:09Speaker 1: as they say, profitable. One has to be able to
- 6:11Speaker 1: make money for it to continue. So break down the
- 6:14Speaker 1: whole process of, you know, when you started, okay, this
- 6:17Speaker 1: is reality. You know, this can actually happen. Did you
- 6:21Speaker 1: go to someone in the medical field for advice? What
- 6:24Speaker 1: did you do?
- 6:26Speaker 3: It's interesting. It was a lot of networking. Right. Yeah.
- 6:30Speaker 3: The question you're asking is really important. Like, how do
- 6:33Speaker 3: I know? that this is a problem that like is
- 6:37Speaker 3: worth solving. Like, are there people who actually use the product?
- 6:41Speaker 3: And so I actually reached out to the private equity
- 6:45Speaker 3: group that owned, um, one of the largest OTPs in
- 6:49Speaker 3: the United States. And I, I just kind of shared
- 6:54Speaker 3: my presentation on like what my vision for our product
- 6:57Speaker 3: would be. And this private equity group was actually like
- 7:00Speaker 3: really interested. And so they introduced me to the CEO,
- 7:03Speaker 3: of one of these large opioid treatment program companies. And,
- 7:07Speaker 3: you know, I think the weight of that introduction coming
- 7:09Speaker 3: from the private equity group, let them take what I
- 7:12Speaker 3: was saying more seriously. And the fact that I was
- 7:15Speaker 3: maybe positioned also helped add some credibility. And so, yeah,
- 7:19Speaker 3: when I shared kind of the concept with the executive
- 7:23Speaker 3: leadership at this opioid treatment program, they were hesitant, but
- 7:27Speaker 3: overall like pretty supportive. And they said, yeah, we would
- 7:30Speaker 3: love to test something like this out. So, yeah.
- 7:34Speaker 1: So, as we all know, the word in the test
- 7:37Speaker 1: period is called the beta period. When you, you know,
- 7:39Speaker 1: you go out there, you're making sure there are no
- 7:41Speaker 1: bugs in the process and there are no bad apples
- 7:45Speaker 1: in the process. Now, when you started choosing, you know,
- 7:50Speaker 1: potential patients for this process, and explain everybody the process
- 7:56Speaker 1: right now.
- 7:58Speaker 3: Oh, so... Before we launched the full product, we did
- 8:03Speaker 3: have kind of like a test version. And we got
- 8:06Speaker 3: funding from the National Institute of Health to pilot our
- 8:11Speaker 3: test version. And one of the pilot sites, like the
- 8:15Speaker 3: very first site, was in the Tenderloin District of San Francisco.
- 8:19Speaker 2: Okay.
- 8:21Speaker 3: And that's kind of like ground zero. Like, if you
- 8:23Speaker 3: really want to find out if your application works, go, like,
- 8:27Speaker 3: you know, to help opioid use disorder, test it out there. Wow.
- 8:31Speaker 1: Why do you say that? I'm just asking. Is it
- 8:34Speaker 1: because of opioid or because it's Silicon Valley with apps
- 8:37Speaker 1: and everything's out there and technology is at such a
- 8:40Speaker 1: high level?
- 8:41Speaker 3: Yeah, because the first thing, the burden of, like, opioid
- 8:45Speaker 3: use disorder is very high, specifically, like, in San Francisco area.
- 8:50Speaker 3: but even more so like in the Tenderloin district, um,
- 8:55Speaker 3: you know, like walking to the clinic from the subway,
- 8:58Speaker 3: you will see people using drugs outside the clinic. You
- 9:01Speaker 3: will see people who are in a state of overdose.
- 9:05Speaker 3: It's like, it's pretty terrifying. And I was like, man,
- 9:08Speaker 3: why are we launching here? This is like, like if
- 9:11Speaker 3: this was like, these patients seem so unstable, like how
- 9:14Speaker 3: are they going to use this application? And I learned
- 9:17Speaker 3: something then because these patients shattered my expectations. All they
- 9:22Speaker 3: needed was just a little bit of something to prove themselves.
- 9:24Speaker 3: And so that's the story.
- 9:27Speaker 1: Well, let me ask you this, Dr. Giles, because I'm
- 9:29Speaker 1: going to tell you something. From a stereotype, San Francisco
- 9:34Speaker 1: wouldn't be the place I would think you would find
- 9:36Speaker 1: in high concentration because I'm thinking high concentration San Francisco
- 9:39Speaker 1: or Liberal, very highly educated community. These are the things
- 9:44Speaker 1: that run through my mind. I'm thinking maybe West Virginia.
- 9:47Speaker 1: I'm thinking maybe Kentucky. I'm thinking rural areas will probably
- 9:52Speaker 1: be high volume usage area. And you telling me, no, Rashaun,
- 9:55Speaker 1: San Francisco. Why do I have this stereotype about people
- 10:00Speaker 1: who use opioids in my head?
- 10:03Speaker 3: Well, the areas you mentioned are kind of where the
- 10:08Speaker 3: epidemic started. So I don't know, maybe there's like a
- 10:11Speaker 3: founder's effect there, but it's spread all across the United
- 10:17Speaker 3: States and, And it's, you know, it is terrible in
- 10:20Speaker 3: the locations you mentioned, but it's also terrible in other
- 10:23Speaker 3: locations people may not always think of. And so, you know,
- 10:27Speaker 3: you have San Francisco, certain parts of it, and it's
- 10:31Speaker 3: growing in San Francisco. And you have, like, Seattle. So, yeah,
- 10:39Speaker 3: it's growing quicker than it's, like, being improved.
- 10:42Speaker 1: You know, it's really interesting. You know, when I was
- 10:44Speaker 1: in high school, I was– I did a study on
- 10:48Speaker 1: drug addicted babies, babies who moms were addicted to drugs
- 10:53Speaker 1: and they came out, they were addicted to drugs. So
- 10:57Speaker 1: that is, you know, that was one of the most
- 10:59Speaker 1: emotional moments in my young life to see that I'm helpless.
- 11:03Speaker 1: I can't do anything about this, you know, you know,
- 11:06Speaker 1: because the problem started before the child was even born.
- 11:09Speaker 1: And so and then you look at this side of
- 11:11Speaker 1: the table. Can you tell me what exactly is opioids?
- 11:18Speaker 3: Yeah, so an opioid is, you know, it's a class
- 11:22Speaker 3: of chemicals naturally occurring in a flower called like the
- 11:27Speaker 3: opium poppy. And it's been used for hundreds of years
- 11:31Speaker 3: for pain control. But it also is like very addictive.
- 11:36Speaker 3: And like the modern forms of kind of the opioid
- 11:40Speaker 3: compound have been refined to the point where they bind
- 11:45Speaker 3: to the like, like pain control and like pleasure receptor
- 11:49Speaker 3: of the brain very, very like strongly. And so, um,
- 11:55Speaker 3: when patients stop taking the opioids, which, you know, now
- 11:59Speaker 3: are often required illicitly and have like fentanyl and super
- 12:04Speaker 3: dangerous things to get, when they stop taking it, they
- 12:06Speaker 3: go into withdrawal and to have a pain, very painful, uh,
- 12:10Speaker 3: flu like illness, but way worse than the flu, you know,
- 12:12Speaker 3: that lasts days usually. Um, And so, yeah, that compels
- 12:17Speaker 3: them to keep using the opioids because they don't want
- 12:20Speaker 3: to go through that experience. And then, you know, as
- 12:23Speaker 3: our brain gets used to the opioid, they'll require higher
- 12:26Speaker 3: and higher doses. And eventually they'll require such a high
- 12:30Speaker 3: dose that they'll overdose, potentially fatal overdose.
- 12:34Speaker 1: Well, you mentioned the drug in there, fentanyl, because I've
- 12:38Speaker 1: heard that drug tied to opioid. Please explain to my
- 12:43Speaker 1: audience and to me. Why does the word fentanyl pop
- 12:46Speaker 1: up a lot when you hear opioid use?
- 12:50Speaker 3: Fentanyl is driving, by and large, the vast majority of
- 12:54Speaker 3: deaths related to drug use currently in the United States.
- 13:00Speaker 3: Old-fashioned opioids like heroin are actually pretty rare now. Fentanyl
- 13:05Speaker 3: is very easy to produce in home laboratories and And
- 13:12Speaker 3: you only need like a few grains of sand of it,
- 13:16Speaker 3: like in the thing you're selling in order to, you know,
- 13:20Speaker 3: satisfy the person who's trying to buy these opioids. And
- 13:25Speaker 3: if you take one or two extra grains of sand
- 13:27Speaker 3: of fentanyl, you could potentially die.
- 13:30Speaker 1: Is that toxic?
- 13:33Speaker 3: Is that toxic? Yes. It's like the dose is micrograms
- 13:36Speaker 3: versus like milligrams for like something like morphine. Yeah.
- 13:42Speaker 1: Thousands of times. First of all, you're doing a great cause.
- 13:46Speaker 1: But also, as an entrepreneur, this is a show about entrepreneurship.
- 13:51Speaker 1: This is a show about being able to take an
- 13:54Speaker 1: idea and turn it into a concept and then validate
- 13:57Speaker 1: that by turning it into a business model. Now, with
- 14:01Speaker 1: that being a business model, because we want to continue
- 14:03Speaker 1: to talk about this because I want to talk about
- 14:04Speaker 1: the use and You know, the care and all that process.
- 14:08Speaker 1: But it just always amazes me when individuals and I
- 14:11Speaker 1: have to use the word visionary when I talk to you,
- 14:13Speaker 1: because I wouldn't have thought about this. That's why I
- 14:15Speaker 1: mentioned to you about my association with drug addicted babies
- 14:20Speaker 1: when I was a senior in high school. So I've
- 14:21Speaker 1: always had this this this emotional connection. caring side of me,
- 14:28Speaker 1: how can we stop this? How can we fix this? Now,
- 14:30Speaker 1: I know my situation is different than yours because yours
- 14:32Speaker 1: is about, you know, opioid use disorder care, methadone. They
- 14:37Speaker 1: have a drug out there that can assist them in
- 14:40Speaker 1: living a normal life. It's about how they are receiving it.
- 14:44Speaker 1: And you're stopping that point of having to come into
- 14:47Speaker 1: an office. And I'm sure the doctors like that because
- 14:51Speaker 1: that doesn't slow them down. The nurses like that doesn't
- 14:53Speaker 1: slow them down as.
- 14:54Speaker 3: Well, correct?
- 14:54Speaker 4: Absolutely.
- 14:56Speaker 3: Right. Yeah. So there's reduced clinic foot traffic when there's
- 15:01Speaker 3: a lot of patients on Sonara. And then you have
- 15:04Speaker 3: improved patient retention. And so like from a revenue perspective
- 15:08Speaker 3: for our customers, the longer a patient is in treatment,
- 15:11Speaker 3: the more revenue the customer makes. So by reducing dropout,
- 15:15Speaker 3: we kind of help customers keep their revenue up.
- 15:18Speaker 1: Cool. I just want to go to break right quick. Dr. Giles,
- 15:22Speaker 1: if anyone wants to call in, because I know the
- 15:25Speaker 1: nature of this may have some questions, may have some
- 15:27Speaker 1: family members that you may want to understand how they
- 15:30Speaker 1: can gain use of this. We're going to find out
- 15:32Speaker 1: exactly the different locations that this is available, how it
- 15:35Speaker 1: can be available as a virtual process. So and that
- 15:39Speaker 1: has to be understood as well. But we return more
- 15:41Speaker 1: with Money Making Conversations Masterclass. with Dr. Michael Giles and
- 15:45Speaker 1: his process of being able to help people with opioid
- 15:49Speaker 1: use disorder.
- 15:51Speaker 4: Please don't go anywhere. We'll be right back with more
- 15:54Speaker 4: Money Making Conversations Masterclass. Welcome back to the Money Making
- 16:05Speaker 4: Conversations Masterclass hosted by Rashawn McDonald. Money Making Conversations Masterclass
- 16:11Speaker 4: continues online at MoneyMakingConversations.com and follow Money Making Conversations Masterclass
- 16:17Speaker 4: on Facebook, Twitter, and Instagram.
- 16:20Speaker 1: My guest is Dr. Michael Giles. He's invented, created a
- 16:26Speaker 1: methadone treatment program that's virtual, which allows individuals who are
- 16:30Speaker 1: going through these programs not having to go into a
- 16:32Speaker 1: doctor's office, but It's an honor system. When they take
- 16:35Speaker 1: the drug, they videotape themselves, and it gets logged in.
- 16:39Speaker 1: Am I shorthanding it correctly there, Dr. Giles?
- 16:44Speaker 3: Yeah, well, without Sonara, it's an honor system. So without Sonara,
- 16:49Speaker 3: you get take-homes, and the provider doesn't really know if
- 16:51Speaker 3: you're taking them or not.
- 16:53Speaker 2: Right.
- 16:54Speaker 3: But with Sonara, you know for sure whether the patient's
- 16:57Speaker 3: taking their medication.
- 16:59Speaker 4: Cool.
- 16:59Speaker 1: Now, how does Sonara, that's the name of the clinic.
- 17:02Speaker 1: Did I say clinic? Sonara Health Clinic?
- 17:06Speaker 3: Our application.
- 17:07Speaker 1: Okay, Sonara Health Clinic. How do they ensure the security
- 17:10Speaker 1: and privacy of patient data and what measures are in
- 17:13Speaker 1: place to comply with these regulatory requirements? Because that's the
- 17:16Speaker 1: number one fear I would have.
- 17:17Speaker 4: Yes.
- 17:19Speaker 1: I always read about somebody holding somebody ransom or breaking into.
- 17:23Speaker 1: How are you protecting a patient's data?
- 17:26Speaker 3: Yes, so we have a healthcare contract with Google's healthcare platform. So,
- 17:32Speaker 3: you know, in order for that platform to be legal,
- 17:35Speaker 3: like Google can't access that data. I can't access that data.
- 17:40Speaker 3: Only the treatment team, like technical support team at Sonara
- 17:45Speaker 3: and the patient have access to that data. And that
- 17:47Speaker 3: data is never used for ads or any other commercial purposes.
- 17:51Speaker 3: It's exclusively for treatment planning.
- 17:55Speaker 1: That's important to know that your information is suddenly not
- 17:58Speaker 1: appearing on some mailing list and they send you concert
- 18:01Speaker 1: tickets and pizza coupons and things like that. This stuff
- 18:05Speaker 1: is locked in. It is used strictly for their patient
- 18:08Speaker 1: care and not distributed. Like you said, Google doesn't gain access.
- 18:12Speaker 1: You don't gain any personal access to this. No one
- 18:14Speaker 1: gains access to this. This is strictly for the health
- 18:17Speaker 1: care patient, the patient's knowledge and their format, correct?
- 18:21Speaker 3: Exactly. The patient and the provider.
- 18:23Speaker 1: You know, we talked about this a little earlier. You said,
- 18:25Speaker 1: you know, basically the doctors feel very comfortable and happy
- 18:29Speaker 1: about this process in our health system. And then the patients,
- 18:33Speaker 1: they're the key. How do you recruit your patients? How
- 18:37Speaker 1: do they find out about your health system? And how
- 18:41Speaker 1: do they respond to it?
- 18:44Speaker 3: Oh, man, the patients respond so well because, you know,
- 18:48Speaker 3: the typical patient story is, you know, I've been going
- 18:52Speaker 3: to the clinic for months to years and I only
- 18:55Speaker 3: have two or three take-home doses a week. And then
- 18:57Speaker 3: all of a sudden I get put on Sonara and
- 18:59Speaker 3: I have, you know, six or 13 take-home doses. And
- 19:04Speaker 3: so like, you know, as a patient, I can now
- 19:06Speaker 3: look for an apartment or get a job. It's pretty life-changing.
- 19:10Speaker 3: And in places like, you know, Alaska where the patient
- 19:14Speaker 3: is driving two hours one way to the clinic and
- 19:17Speaker 3: I mean, it's literally like the most kind of freedom
- 19:21Speaker 3: enhancing moment that these patients have had in a long time.
- 19:25Speaker 3: So patients love it. And in terms of like how
- 19:27Speaker 3: we choose which patients get put on it. So when
- 19:31Speaker 3: we're implementing at a clinic, we work with the clinical
- 19:35Speaker 3: team there to kind of draft new clinical criteria for
- 19:40Speaker 3: who should be given Sonara and you know, how quickly
- 19:45Speaker 3: they should be getting take-homes. And on average, you know,
- 19:49Speaker 3: patients on Sonara with the schedules that we created at
- 19:51Speaker 3: these clinics have twice the number of take-homes compared to
- 19:55Speaker 3: a patient who's been on Sonara, or sorry, who hasn't
- 19:58Speaker 3: been on Sonara.
- 20:01Speaker 1: Sonara, the name. How did you come up with the
- 20:04Speaker 1: name and why tied to this particular process? Sonara.
- 20:07Speaker 3: I mean, we were... brainstorming names and someone in our company,
- 20:15Speaker 3: you know, who speaks Spanish said the word to dream,
- 20:19Speaker 3: like the future tense to dream is the word Sonata.
- 20:23Speaker 3: And I thought that was a really cool name. So,
- 20:26Speaker 3: you know, we want patients to dream of like a
- 20:28Speaker 3: future where they have freedom. So it just seemed very fitting.
- 20:32Speaker 1: It's powerful. It's not only fitting, but it's powerful because,
- 20:35Speaker 1: you know, because this is the educational part to me.
- 20:38Speaker 1: Because you're going through life and somehow opioid falls into
- 20:44Speaker 1: your life and you call it opioid use disorder, OUD.
- 20:49Speaker 1: You commit to a methadone treatment program. Do you ever
- 20:53Speaker 1: get off the program, Dr.
- 20:54Speaker 3: Giles? Yeah, that's what the patient's goals are. So I
- 21:01Speaker 3: wish we were at a point where that was like
- 21:03Speaker 3: the focus. But right now, like most patients drop out
- 21:07Speaker 3: of treatment within the first 60 days. And, you know,
- 21:12Speaker 3: as soon as that happens, the risk of like having
- 21:14Speaker 3: a fatal overdose increases by nearly 300%. And so, you know,
- 21:20Speaker 3: the minimum amount of treatment time for the American Society
- 21:23Speaker 3: of Addiction Medicine is one year. So when we can
- 21:26Speaker 3: start getting most patients to one year, I really want
- 21:30Speaker 3: to start thinking about answering the question you mentioned, like
- 21:32Speaker 3: how do we taper patients off and, you know, eventually
- 21:37Speaker 3: they don't need anything. But until we can solve this
- 21:40Speaker 3: kind of crisis in the first 60 days, we just
- 21:44Speaker 3: don't have the bandwidth to solve that other thing right now.
- 21:48Speaker 1: Wow. Because, you know, it's like... How do you get
- 21:52Speaker 1: your life back if it's still tied to a treatment program?
- 21:56Speaker 1: How do you gain confidence? How do you have a relationship?
- 21:58Speaker 1: How do you do anything? How do you move on
- 22:02Speaker 1: with this treatment program? It seems like it's forever going on. Now,
- 22:07Speaker 1: it's always tied to anything. Just because there's a program
- 22:09Speaker 1: out there, you have to have eligibility criteria tied to it. So, Nara,
- 22:13Speaker 1: what are the eligibility criteria? And also, again, this is
- 22:16Speaker 1: a virtual process, and before you talk about eligibility criteria,
- 22:20Speaker 1: Tell them again how it works, Dr.
- 22:21Speaker 3: Giles. Yeah, so the way the application works is patients
- 22:27Speaker 3: will get their take-home methadone. It'll have a special label
- 22:31Speaker 3: on the bottle. And, you know, there's one dose per bottle,
- 22:35Speaker 3: and you just use one bottle per day. And so
- 22:38Speaker 3: you're at home with all these bottles, and, you know,
- 22:40Speaker 3: you log into Synar.app, and you press the Take My
- 22:43Speaker 3: Dose button. And so then it'll ask you to scan
- 22:46Speaker 3: the QR code on the methadone bottle. Um, so yeah,
- 22:50Speaker 3: you'll scan it and then it'll, you know, we'll confirm
- 22:53Speaker 3: that that bottle has never been scanned or used before.
- 22:55Speaker 3: And then it'll flip to the front facing camera and,
- 22:59Speaker 3: you know, we give the patient cell phone stands. And
- 23:02Speaker 3: so the patient will put the cell phone on the
- 23:05Speaker 3: cell phone stand and they'll open the bottle and take
- 23:07Speaker 3: the medication. Um, and so, you know, that whole process
- 23:10Speaker 3: takes about 72 seconds on average across the hundreds of
- 23:14Speaker 3: thousands of doses we've recorded.
- 23:16Speaker 4: Okay.
- 23:16Speaker 3: You compare that 72 seconds to hours of your day
- 23:20Speaker 3: if you're not using Sonara when you're having to go
- 23:23Speaker 3: to the clinic.
- 23:23Speaker 1: That's the process. So how does one, as a patient,
- 23:27Speaker 1: qualify or what is the criteria to qualify for the
- 23:32Speaker 1: use of this type of Sonara health solution?
- 23:37Speaker 3: Now, that is a much more complicated question, unfortunately. So, like...
- 23:42Speaker 3: Methadone is probably the most regulated medication in the United States.
- 23:47Speaker 3: And every state has their own rules for how methadone
- 23:51Speaker 3: can be prescribed. So it really will vary from state
- 23:56Speaker 3: to state. And then on top of that, every clinic
- 23:59Speaker 3: has their own culture. And, you know, our job at
- 24:02Speaker 3: SNAR is to try to make clinics have the most
- 24:04Speaker 3: kind of patient-centered culture possible. But the best answer to
- 24:09Speaker 3: that question is really going to depend on where the
- 24:11Speaker 3: patients live. But you have some common factors, though, like
- 24:15Speaker 3: you're on a stable dose of methadone, so you're not
- 24:18Speaker 3: needing to go up and down all the time in
- 24:20Speaker 3: your dose. Wow. You know, attendance hasn't been too much
- 24:25Speaker 3: of an issue. Conversely, right, if attendance is an issue,
- 24:28Speaker 3: maybe you need Sonara.
- 24:30Speaker 1: Right.
- 24:30Speaker 3: So it really depends on kind of the clinics.
- 24:34Speaker 1: Well, you know, the thing about you're based in Houston, Texas, correct?
- 24:38Speaker 3: Dallas.
- 24:38Speaker 1: Dallas, Texas. You're based in Dallas, Texas. I apologize. Sonara
- 24:41Speaker 1: Health Solutions. And now, what's the future? You know, you
- 24:45Speaker 1: got it rolling. We know this is a business. Your
- 24:49Speaker 1: entrepreneurship has kicked in, but it's also helping people get
- 24:54Speaker 1: their lives back. What is in product development or outreach program?
- 24:59Speaker 1: What do you have? What's the next step for Sonara
- 25:01Speaker 1: Health Solutions?
- 25:03Speaker 3: Yeah, so... Right now, our application is really centered on
- 25:07Speaker 3: kind of this virtual dosing window experience, you know, recreating
- 25:11Speaker 3: the in-person dosing, but like more conveniently from your cell
- 25:15Speaker 3: phone at your home. We want to expand that to
- 25:18Speaker 3: be more broadly just patient engagement, specifically to kind of
- 25:23Speaker 3: answer one of the questions you asked earlier, like how
- 25:25Speaker 3: does the patient come off the system, right? So we
- 25:28Speaker 3: don't want the patient's tech to record every day if
- 25:30Speaker 3: they're clinically stable. It's intrusive and not nice, right? And
- 25:34Speaker 3: so we'll just have kind of more generally useful patient
- 25:38Speaker 3: engagement tools like messaging, counseling sessions, virtual intakes, things like that.
- 25:45Speaker 3: So that's kind of the future of our product.
- 25:48Speaker 1: Well, you know something, Dr. Giles, I'm proud of you,
- 25:50Speaker 1: my man. You know, I say that because not many people,
- 25:57Speaker 1: you know, there are people out there making money off
- 25:59Speaker 1: of cars and making money off of, hamburgers and businesses
- 26:04Speaker 1: set up. And these are fantastic. There are not many
- 26:07Speaker 1: businesses that are set up to save people's lives and
- 26:10Speaker 1: change communities. And that's what you're doing. You know, if
- 26:14Speaker 1: nobody's saying that to you, let me say that to
- 26:16Speaker 1: you because of the fact that I was in the
- 26:19Speaker 1: hospital for 30 days one time in my life and
- 26:22Speaker 1: they had a drug attached to me because I was
- 26:24Speaker 1: in so much pain. I would press a button. And
- 26:28Speaker 1: now after a while, the drug will stop entering my system,
- 26:30Speaker 1: but I kept pressing that button. because they knew if
- 26:33Speaker 1: I just kept pressing that button, I would become addicted
- 26:35Speaker 1: to that drug. So eventually I had to learn to
- 26:37Speaker 1: live with the pain, and eventually I got off of it.
- 26:40Speaker 1: They weaned me off of that machine. So I know
- 26:43Speaker 1: what addiction can feel like. I know the impact of
- 26:47Speaker 1: that machine not being managed correctly, how it could have
- 26:51Speaker 1: impacted my life today. But I brought you on this show.
- 26:55Speaker 1: You're a different type of entrepreneur I brought on this show,
- 26:58Speaker 1: but I thought it was necessary for people to hear
- 27:00Speaker 1: that there are many ways people out there being entrepreneurs,
- 27:04Speaker 1: changing people's lives, and being a positive force in the community.
- 27:08Speaker 1: And that's what you are, my brother. And I always
- 27:10Speaker 1: know I'm a fan. And as I always say in
- 27:13Speaker 1: my show, I close it out with the word keep winning.
- 27:15Speaker 1: I'm going to tell you, my friend, keep winning. As
- 27:18Speaker 1: we close, is there any contact information you want to
- 27:20Speaker 1: share with my audience?
- 27:23Speaker 3: Yeah. If anyone's interested in Sinoff, feel free to email phil.com.
- 27:30Speaker 3: P-H-I-L at sonarhealth.com and we will reach it back out
- 27:35Speaker 3: to you. Cool.
- 27:36Speaker 1: Thank you, my friend, for taking the time to come
- 27:37Speaker 1: on Money Making Conversations Masterclass. Stay safe, okay?
- 27:41Speaker 3: You too. Thank you, Rashawn.
- 27:43Speaker 1: This has been another edition of Money Making Conversations Masterclass
- 27:47Speaker 1: hosted by me, Rashawn McDonald. Thank you to our guests
- 27:50Speaker 1: on the show today and thank you, our listening audience. Now,
- 27:53Speaker 1: if you want to listen to any episode or want
- 27:55Speaker 1: to be a guest on the show, visit moneymakingconversations.com. Our
- 27:59Speaker 1: social media handle is Money Making Conversation. Join us next
- 28:03Speaker 1: week and remember to always lead with your gifts. Keep winning.